DA Davidson analyst Brian Holland lowered the firm’s price target on Vital Farms to $44 from $54 but keeps a Buy rating on the shares. The company’s Q2 results were “exceptional but expected”, though its second-half outlook inclusive of high single digit EBITDA margins was not, the analyst tells investors in a research note. A fair amount of conservatism continues to be embedded within the guide however, the firm added.
Meet Your ETF AI Analyst
- Discover how TipRanks' ETF AI Analyst can help you make smarter investment decisions
- Explore ETFs TipRanks' users love and see what insights the ETF AI Analyst reveals about the ones you follow.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on VITL:
- Vital Farms sees FY24 revenue at least $590M, consensus $585.76M
- Vital Farms reports Q2 EPS 36c, consensus 20c
- Vital Farms to Report Second Quarter 2024 Financial Results on August 8, 2024
- Vital Farms price target raised to $42 from $40 at Stifel
- Up 302% YoY, Is Vital Farms Stock (NYSE:VITL) Still a Buy?